Probiotics, antibiotics and the immune responses to vaccines

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1671, 2015, Pages

  Praharaj, Ira ^a   John, Sushil M ^a   Bandyopadhyay, Rini ^a   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Anthelminthics; Antibiotics; Microbiota; Oral vaccines; Probiotics; Vaccines

Indexed keywords

ANTIBIOTICS; CHOLERA; DEVELOPING WORLD; IMMUNE RESPONSE; PROBIOTICS; VACCINATION;

ANIMALIA;

ANTIINFECTIVE AGENT; PROBIOTIC AGENT; VACCINE;

DEVELOPING COUNTRY; HUMAN; IMMUNOLOGY; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; DEVELOPING COUNTRIES; HUMANS; PROBIOTICS; VACCINES;

EID: 84929250722     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0144     Document Type: Review

References (105)

1. Greenberg HB, Estes MK. 2009 Rotaviruses: from pathogenesis to vaccination. Gastroenterol 136, 1939–1951. (doi:10.1053/j.gastro.2009.02.076)
2. Madhi SA et al. 2010 Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl. J. Med. 362, 289–298. (doi:10.1056/NEJMoa0904797)
3. Zaman K et al. 2010 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebocontrolled trial. Lancet 376, 615–623. (doi:10.1016/S0140-6736(10)60755-6)
4. Armah GE et al. 2010 Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376, 606–614. (doi:10.1016/S0140-6736(10)60889-6)
5. Patel M et al. 2009 Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. J. Am. Med. Assoc. 301, 2243–2251. (doi:10.1001/jama.2009.756)
6. Patel MM et al. 2013 Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study. Br. Med. J. 346, f3726. (doi:10.1136/bmj.f3726)
7. John TJ. 1976 Antibody response of infants in tropics to five doses of oral polio vaccine. Br. Med. J. 1, 812. (doi:10.1136/bmj.1.6013.812)
8. John TJ, Jayabal P. 1972 Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am. J. Epidemiol. 96, 263–269.
9. Patriarca PA, Wright PF, John TJ. 1991 Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev. Infect. Dis. 13, 926–939. (doi:10.1093/clinids/13.5.926)
10. Clarke E, Desselberger U. 2015 Correlates of protection against human rotavirus disease and the factors influencing protection in low-income settings. Mucosal Immunol. 8, 1–17. (doi:10.1038/mi.2014.114)
11. Lopez AL, Gonzales ML, Aldaba JG, Nair GB. 2014 Killed oral cholera vaccines: history, development and implementation challenges. Ther. Adv. Vaccines 2, 123–136. (doi:10.1177/2051013614 537819)
12. Qadri F, Bhuiyan TR, Sack DA, Svennerholm AM. 2013 Immune responses and protection in children in developing countries induced by oral vaccines. Vaccine 31, 452–460. (doi:10.1016/j.vaccine.2012.11.012)
13. Serazin AC, Shackelton LA, Wilson C, Bhan MK. 2010 Improving the performance of enteric vaccines in the developing world. Nat. Immunol. 11, 769–773. (doi:10.1038/ni0910-769)
14. Katz M, Plotkin SA. 1968 Oral polio immunization of the newborn infant; a possible method for overcoming interference by ingested antibodies. J. Pediatr. 73, 267–270. (doi:10.1016/S0022-3476(68)80084-8)
15. Katz M, Brown RE, Plotkin SA. 1968 Oral poliovirus vaccination in newborn African infants: relative ineffectiveness of early feeding of vaccine. Trop. Geogr. Med. 20, 133–136.
16. John TJ, Devarajan LV, Luther L, Vijayarathnam P. 1976 Effect of breast-feeding on seroresponse of infants to oral poliovirus vaccination. Pediatrics 57, 47–53.
17. Deforest A, Parker PB, DiLiberti JH, Yates Jr HT, Sibinga MS, Smith DS. 1973 The effect of breastfeeding on the antibody response of infants to trivalent oral poliovirus vaccine. J. Pediatr. 83, 93–95. (doi:10.1016/S0022-3476(73)80323-3)
18. Anonymous. 1970 Report of the committee on infectious diseases, p. 56. Evanston, IL: American Academy of Pediatrics.
19. Glass RI, Stoll BJ, Wyatt RG, Hoshino Y, Banu H, Kapikian AZ. 1986 Observations questioning a protective role for breast-feeding in severe rotavirus diarrhea. Acta Paediatr. Scand. 75, 713–718. (doi:10.1111/j.1651-2227.1986.tb10279.x)
20. Moon SS et al. 2010 Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr. Infect. Dis. J. 29, 919–923. (doi:10.1097/INF.0b013e3181e232ea)
21. Appaiahgari MB, Glass R, Singh S, Taneja S, Rongsen-Chandola T, Bhandari N, Mishra S, Vrati S. 2014 Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine 32, 651–656. (doi:10.1016/j.vaccine.2013.12.017)
22. Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, Jiang B, Parashar UD, Madhi SA. 2014 Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull. World Health Organ. 92, 238–245. (doi:10.2471/BLT.13.128066)
23. Rongsen-Chandola T et al. 2014 Effect of withholding breastfeeding on the immune response to a live oral rotavirus vaccine in North Indian infants. Vaccine 32(Suppl. 1), A134–A139. (doi:10.1016/j.vaccine.2014.04.078)
24. Duerkop BA, Vaishnava S, Hooper LV. 2009 Immune responses to the microbiota at the intestinal mucosal surface. Immunity 31, 368–376. (doi:10.1016/j.immuni.2009.08.009)
25. Hooper LV, Littman DR, Macpherson AJ. 2012 Interactions between the microbiota and the immune system. Science 336, 1268–1273. (doi:10.1126/science.1223490)
26. Homes R, Hourihane OB, Booth CC. 1961 The mucosa of the small intestine. Postgrad. Med. J. 37, 717–724. (doi:10.1136/pgmj.37.434.717)
27. Sprinz H, Sribhibhadh R, Gangarosa EJ, Benyajati C, Kundel D, Halstead S. 1962 Biopsy of small bowel of Thai people. With special reference to recovery from Asiatic cholera and to an intestinal malabsorption syndrome. Am. J. Clin. Pathol. 38, 43–51.
28. Baker SJ. 1976 Subclinical intestinal malabsorption in developing countries. Bull. World Health Organ. 54, 485–494.
29. Challacombe DN, Richardson JM, Anderson CM. 1974 Bacterial microflora of the upper gastrointestinal tract in infants without diarrhoea. Arch. Dis. Child. 49, 264–269. (doi:10.1136/adc.49.4.264)
30. Bishop RF, Barnes GL, Townley RR. 1974 Microbial flora of stomach and small intestine in infantile gastroenteritis. Acta Paediatr. Scand. 63, 418–422. (doi:10.1111/j.1651-2227.1974.tb04820.x)
31. Albert MJ, Bhat P, Rajan D, Maiya PP, Pereira SM, Mathan M, Baker SJ. 1978 Jejunal microbial flora of southern Indian infants in health and with acute gastroenteritis. J. Med. Microbiol. 11, 433–440. (doi:10.1099/00222615-11-4-433)
32. Lin A, Bik EM, Costello EK, Dethlefsen L, Haque R, Relman DA, Singh U. 2013 Distinct distal gut microbiome diversity and composition in healthy children from Bangladesh and the United States. PLoS ONE 8, e53838. (doi:10.1371/journal.pone.0053838)
33. Yatsunenko T et al. 2012 Human gut microbiome viewed across age and geography. Nature 486, 222–227.
34. Azad MB et al. 2013 Gut microbiota of healthy Canadian infants: profiles by mode of delivery and infant diet at 4 months. Can. Med. Assoc. J. 185, 385–394. (doi:10.1503/cmaj.121189)
35. Kotloff KL et al. 2013 Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382, 209–222. (doi:10.1016/S0140-6736(13)60844-2)
36. Swierczewski BE et al. 2013 Surveillance for enteric pathogens in a case-control study of acute diarrhea in Western Kenya. Trans. R. Soc. Trop. Med. Hyg. 107, 83–90. (doi:10.1093/trstmh/trs022)
37. Bodhidatta L, McDaniel P, Sornsakrin S, Srijan A, Serichantalergs O, Mason CJ. 2010 Case-control study of diarrheal disease etiology in a remote rural area in Western Thailand. Am. J. Trop. Med. Hyg. 83, 1106–1109. (doi:10.4269/ajtmh.2010.10-0367)
38. Ajjampur SS et al. 2008 Closing the diarrhoea diagnostic gap in Indian children by the application of molecular techniques. J. Med. Microbiol. 57, 1364–1368. (doi:10.1099/jmm.0.2008/003319-0)
39. Valdez Y, Brown EM, Finlay BB. 2014 Influence of the microbiota on vaccine effectiveness. Trends Immunol. 35, 526–537. (doi:10.1016/j.it.2014.07.003)
40. Keusch GT et al. 2013 Implications of acquired environmental enteric dysfunction for growth and stunting in infants and children living in lowand middle-income countries. Food Nutr. Bull. 34, 357–364.
41. Campbell DI, McPhail G, Lunn PG, Elia M, Jeffries DJ. 2004 Intestinal inflammation measured by fecal neopterin in Gambian children with enteropathy: association with growth failure, Giardia lamblia, and intestinal permeability. J. Pediatr. Gastroenterol. Nutr. 39, 153–157. (doi:10.1097/00005176-2004 08000-00005)
42. Campbell DI, Murch SH, Elia M, Sullivan PB, Sanyang MS, Jobarteh B, Lunn PG. 2003 Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatr. Res. 54, 306–311. (doi:10.1203/01.PDR.0000076666.16021.5E)
43. Campbell DI, Elia M, Lunn PG. 2003 Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation. J. Nutr. 133, 1332–1338.
44. Korpe PS, Petri Jr WA. 2012 Environmental enteropathy: critical implications of a poorly understood condition. Trends Mol. Med. 18, 328–336. (doi:10.1016/j.molmed.2012.04.007)
45. Lunn PG, Northrop-Clewes CA, Downes RM. 1991 Intestinal permeability, mucosal injury, and growth faltering in Gambian infants. Lancet 338, 907–910. (doi:10.1016/0140-6736(91)91772-M)
46. Dethlefsen L, McFall-Ngai M, Relman DA. 2007 An ecological and evolutionary perspective on human–microbe mutualism and disease. Nature 449, 811–818. (doi:10.1038/nature06245)
47. Ferreira RB, Antunes LC, Finlay BB. 2010 Should the human microbiome be considered when developing vaccines? PLoS Pathog. 6, e1001190. (doi:10.1371/journal.ppat.1001190)
48. Chinen T, Rudensky AY. 2012 The effects of commensal microbiota on immune cell subsets and inflammatory responses. Immunol. Rev. 245, 45–55. (doi:10.1111/j.1600-065X.2011.01083.x)
49. Goto Y, Kiyono H. 2012 Epithelial barrier: an interface for the cross-communication between gut flora and immune system. Immunol. Rev. 245, 147–163. (doi:10.1111/j.1600-065X.2011.01078.x)
50. Singh N et al. 2014 Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40, 128–139. (doi:10.1016/j.immuni.2013.12.007)
51. Willing BP et al. 2010 A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139, 1844–1854. (doi:10.1053/j.gastro.2010.08.049)
52. Shan M et al. 2013 Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals. Science 342, 447–453. (doi:10.1126/science.1237910)
53. Vaishnava S, Yamamoto M, Severson KM, Ruhn KA, Yu X, Koren O, Ley R, Wakeland EK, Hooper LV. 2011 The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine. Science 334, 255–258. (doi:10.1126/science.1209791)
54. Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, Laufer TM, Ignatowicz L, Ivanov II. 2014 Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40, 594–607. (doi:10.1016/j.immuni.2014.03.005)
55. Round JL, Mazmanian SK. 2010 Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc. Natl Acad. Sci. USA 107, 12204–12209. (doi:10.1073/pnas.0909122107)
56. Atarashi K et al. 2013 Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236. (doi:10.1038/nature12331)
57. Hapfelmeier S et al. 2010 Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science 328, 1705–1709. (doi:10.1126/science.1188454)
58. Macpherson AJ, Geuking MB, Slack E, Hapfelmeier S, McCoy KD. 2012 The habitat, double life, citizenship, and forgetfulness of IgA. Immunol. Rev. 245, 132–146. (doi:10.1111/j.1600-065X.2011.01072.x)
59. Stecher B et al. 2010 Like will to like: abundances of closely related species can predict susceptibility to intestinal colonization by pathogenic and commensal bacteria. PLoS Pathog. 6, e1000711. (doi:10.1371/journal.ppat.1000711)
60. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, Dermody TS, Pfeiffer JK. 2011 Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 334, 249–252. (doi:10.1126/science.1211057)
61. Robinson CM, Jesudhasan PR, Pfeiffer JK. 2014 Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 15, 36–46. (doi:10.1016/j.chom.2013.12.004)
62. Jones MK et al. 2014 Enteric bacteria promote human and mouse norovirus infection of B cells. Science 346, 755–759. (doi:10.1126/science.1257147)
63. Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagán AJ, Pepper M, Maynard CL, Elson 3rd CO, Belkaid Y. 2012 Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science 337, 1553–1556. (doi:10.1126/science.1220961)
64. Kabat AM, Srinivasan N, Maloy KJ. 2014 Modulation of immune development and function by intestinal microbiota. Trends Immunol. 35, 507–517. (doi:10.1016/j.it.2014.07.010)
65. Pang IK, Iwasaki A. 2011 Control of antiviral immunity by pattern recognition and the microbiome. Immunol. Rev. 245, 209–226. (doi:10.1111/j.1600-065X.2011.01073.x)
66. Thomas CM, Versalovic J. 2010 Probiotics–host communication: modulation of signaling pathways in the intestine. Gut Microbes 1, 148–163. (doi:10.4161/gmic.1.3.11712)
67. Lin PW et al. 2009 Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic. Biol. Med. 47, 1205–1211. (doi:10.1016/j.freeradbiomed.2009.07.033)
68. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, Schneewind O, Chang EB, Petrof EO. 2006 Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am. J. Physiol. Cell Physiol. 290, C1018. (doi:10.1152/ajpcell.00131.2005)
69. Petrof EO, Kojima K, Ropeleski MJ, Musch MW, Tao Y, De Simone C, Chang EB. 2004 Probiotics inhibit nuclear factor-kappaB and induce heat shock proteins in colonic epithelial cells through proteasome inhibition. Gastroenterology 127, 1474–1487. (doi:10.1053/j.gastro.2004.09.001)
70. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. 2007 Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562–575. (doi:10.1053/j.gastro.2006.11.022)
71. Ibnou-Zekri N, Blum S, Schiffrin EJ, von der Weid T. 2003 Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro. Infect. Immun. 71, 428–436. (doi:10.1128/IAI.71.1.428-436.2003)
72. de Roock S, van Elk M, van Dijk ME, Timmerman HM, Rijkers GT, Prakken BJ, Hoekstra MO, de Kleer IM. 2010 Lactic acid bacteria differ in their ability to induce functional regulatory T cells in humans. Clin. Exp. Allergy 40, 103–110. (doi:10.1111/j.1365-2222.2009.03344.x)
73. Kandasamy S, Chattha KS, Vlasova AN, Rajashekara G, Saif LJ. 2014 Lactobacilli and Bifidobacteria enhance mucosal B cell responses and differentially modulate systemic antibody responses to an oral human rotavirus vaccine in a neonatal gnotobiotic pig disease model. Gut Microbes 5, 639–651. (doi:10.4161/19490976.2014.969972)
74. Chattha KS, Vlasova AN, Kandasamy S, Rajashekara G, Saif LJ. 2013 Divergent immunomodulating effects of probiotics on T cell responses to oral attenuated human rotavirus vaccine and virulent human rotavirus infection in a neonatal gnotobiotic piglet disease model. J. Immunol. 191, 2446–2456. (doi:10.4049/jimmunol.1300678)
75. Chattha KS, Vlasova AN, Kandasamy S, Esseili MA, Siegismund C, Rajashekara G, Saif LJ. 2013 Probiotics and colostrum/milk differentially affect neonatal humoral immune responses to oral rotavirus vaccine. Vaccine 31, 1916–1923. (doi:10.1016/j.vaccine.2013.02.020)
76. Zhang W, Azevedo MS, Wen K, Gonzalez A, Saif LJ, Li G, Yousef AE, Yuan L. 2008 Probiotic Lactobacillus acidophilus enhances the immunogenicity of an oral rotavirus vaccine in gnotobiotic pigs. Vaccine 26, 3655–3661. (doi:10.1016/j.vaccine.2008.04.070)
77. Wen K, Li G, Bui T, Liu F, Li Y, Kocher J, Lin L, Yang X, Yuan L. 2012 High dose and low dose Lactobacillus acidophilus exerted differential immune modulating effects on T cell immune responses induced by an oral human rotavirus vaccine in gnotobiotic pigs. Vaccine 30, 1198–1207. (doi:10.1016/j.vaccine.2011.11.107)
78. Isolauri E, Joensuu J, Suomalainen H, Luomala M, Vesikari T. 1995 Improved immunogenicity of oral D_RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310–312. (doi:10.1016/0264-410X(95)93319-5)
79. Matsuda F et al. 2011 Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind, placebo-controlled trial in Bangladeshi children under 5 years of age. Vaccine 29, 1855–1858. (doi:10.1016/j.vaccine.2010.12.133)
80. Soh SE, Ong DQ, Gerez I, Zhang X, Chollate P, Shek LPC, Lee BW, Aw M. 2010 Effect of probiotic supplementation in the first 6 months of life on specific antibody responses to infant hepatitis B vaccination. Vaccine 28, 2577–2579. (doi:10.1016/j.vaccine.2010.01.020)
81. Kukkonen K, Nieminen T, Poussa T, Savilahti E, Kuitunen M. 2006 Effect of probiotics on vaccine antibody responses in infancy: randomized, doubleblind, placebo-controlled trial. Pediatr. Allergy Immunol. 17, 416–421. (doi:10.1111/j.1399-3038.2006.00420.x)
82. Licciardi PV, Ismail IH, Balloch A, Mui M, Hoe E, Lamb K, Tang ML. 2013 Maternal supplementation with LGG reduces vaccine-specific immune responses in infants at high-risk of developing allergic disease. Front. Immunol. 4, 381. (doi:10.3389/fimmu.2013.00381)
83. Taylor A, Hale J, Wiltschut J, Lehmann H, Dunstan JA, Prescott SL. 2006 Evaluation of the effects of probiotic supplementation from the neonatal period on innate immune development in infancy. Clin. Exp. Allergy 36, 1218–1226. (doi:10.1111/j.1365-2222.2006.02552.x)
84. West CE, Gothefors L, Granstrom M, Kayhty H, Hammarstrom ML, Hernell O. 2008 Effects of feeding probiotics during weaning on infections and antibody responses to diphtheria, tetanus and Hib vaccines. Pediatr. Allergy Immunol. 19, 53–60. (doi:10.1111/j.1399-3038.2007.00583.x)
85. Youngster I, Kozer E, Lazarovitch Z, Broide E, Goldman M. 2011 Probiotics and the immunological response to infant vaccinations: a prospective, placebo controlled pilot study. Arch. Dis. Child. 96, 345–349. (doi:10.1136/adc.2010.197459)
86. Perez N et al. 2010 Effect of probiotic supplementation on immunoglobulins, isoagglutinins and antibody response in children of low socio-economic status. Eur. J. Nutr. 49, 173–179. (doi:10.1007/s00394-009-0063-5)
87. Paineau D et al. 2008 Effects of seven potential probiotic strains on specific immune responses in healthy adults: a double-blind, randomized controlled trial. FEMS Immunol. Med. Microbiol. 53, 107–113. (doi:10.1111/j.1574-695X.2008.00413.x)
88. Fang H, Elina T, Heikki A, Seppo S. 2000 Modulation of humoral immune response through probiotic intake. FEMS Immunol. Med. Microbiol. 29, 47–52. (doi:10.1111/j.1574-695X.2000.tb01504.x)
89. de Vrese M, Rautenberg P, Laue C, Koopmans M, Herremans T, Schrezenmeir J. 2005 Probiotic bacteria stimulate virus specific neutralizing antibodies following a booster polio vaccination. Eur. J. Nutr. 44, 406–413. (doi:10.1007/s00394-004-0541-8)
90. Davidson LE, Fiorino AM, Snydman DR, Hibberd PL. 2011 Lactobacillus GG as an immune adjuvant for live-attenuated influenza vaccine in healthy adults: a randomized double blind placebo-controlled trial. Eur. J. Clin. Nutr. 65, 501–507. (doi:10.1038/ejcn.2010.289)
91. Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodńguez JM, Xaus J. 2007 Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23, 254–260. (doi:10.1016/j.nut.2007.01.004)
92. Rizzardini G, Eskesen D, Calder PC, Capetti A, Jespersen L, Clerici M. 2012 Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12 and Lactobacillus paracasei ssp. paracasei, L. casei 431 in an influenza vaccination model: a randomised, double-blind, placebo-controlled study. Br. J. Nutr. 107, 876–884. (doi:10.1017/S000711451100420X)
93. Bunout D et al. 2004 Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J. Parenter. Enteral Nutr. 28, 348–354. (doi:10.1177/0148607104028005348)
94. Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet- Sicard R, van der Werf S. 2009 A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomized controlled trials. Vaccine 27, 5677–5684. (doi:10.1016/j.vaccine.2009.06.094)
95. Bosch M, Mendez M, Perez M, Farran A, Fuentes MC, Cune J. 2012 Lactobacillus plantarum CECT7315 and CECT7316 stimulate immunoglobulin production after influenza vaccination in elderly. Nutr. Hosp. 27, 504–509.
96. Akatsu H, Arakawa K, Yamamoto T, Kanematsu T, Matsukawa N, Ohara H, Maruyama M. 2013 Lactobacillus in jelly enhances the effect of influenza vaccination in elderly individuals. J. Am. Geriatr. Soc. 61, 1828–1830. (doi:10.1111/jgs.12474)
97. Cooper PJ et al. 2000 Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated Oral Cholera Vaccine CVD 103-HgR. J. Infect. Dis. 182, 1199–1206. (doi:10.1086/315837)
98. Cooper PJ, Chico M, Sandoval C, Espinel I, Guevara A, Levine MM, Griffin GE, Nutman TB. 2001 Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun. 69, 1574–1580. (doi:10.1128/IAI.69.3.1574-1580.2001)
99. Webb EL et al. 2011 Effect of single-dose anthelmintic treatment during pregnancy on an infant’s response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind plcebo-controlled trial. Lancet 377, 52–62. (doi:10.1016/S0140-6736(10)61457-2)
100. Lule SA, Mawa PA, Nkurunungi G, Nampijja M, Kizito D, Akello F, Muhangi L, Elliott AM, Webb EL. 2014 Factors associated with tuberculosis infection, and with anti-mycobacterial immune responses, among five year olds BCG-immunised at birth in Entebbe, Uganda. Vaccine. 33, 796–804. (doi:10.1016/j.vaccine.2014.12.015)
101. Cooper PJ et al. 2011 Impact of early life exposures to geohelminth infections on the development of vaccine immunity, allergic sensitization, and allergic inflammatory diseases in children living in tropical Ecuador: the ECUAVIDA birth cohort study. BMC Infect Dis. 11, 1–16. (doi:10.1186/1471-2334-11-184)
102. Labeaud AD, Malhotra I, King MJ, King CL, King CH. 2009 Do antenatal parasite infections devalue childhood vaccination? PLoS Negl. Trop. Dis. 3, e442. (doi:10.1371/journal.pntd.0000442)
103. Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. 2014 Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity. J. Infect. Dis. 210, 171–182. (doi:10.1093/infdis/jiu037)
104. Eloe-Fadrosh EA, McArthur MA, Seekatz AM, Drabek EF, Rasko DA, Sztein MB, Fraser CM. 2013 Impact of oral typhoid vaccination on the human gut microbiota and correlations with S. Typhi-specific immunological responses. PLoS ONE 8, e62026. (doi:10.1371/journal.pone.0062026)
105. Kernbauer E, Ding Y, Cadwell K. 2014 An enteric virus can replace the beneficial function of commensal bacteria. Nature 516, 94–98. (doi:10.1038/nature13960)